Colorectal cancer cell membrane biomimetic ferroferric oxide nanomaterials for homologous bio-imaging and chemotherapy application

被引:0
作者
Jun Li
Chenyu Lin
Yuqian Zhu
Chengwei Shao
Tiegong Wang
Bingdi Chen
机构
[1] The Institute for Biomedical Engineering and Nano Science,Department of Radiology
[2] Tongji University School of Medicine,undefined
[3] Changhai Hospital of Shanghai,undefined
[4] Naval Medical University,undefined
来源
Medical Oncology | / 40卷
关键词
Colorectal cancer; MRI; Fe; O; Cell membrane; Lycorine hydrochloride;
D O I
暂无
中图分类号
学科分类号
摘要
The research of nanomaterials for bio-imaging and theranostic are very active nowadays with unprecedented advantages in nanomedicine. Homologous targeting and bio-imaging greatly improve the ability of targeted drug delivery and enhance active targeting and treatment ability of nanomedicine for the tumor. In this work, lycorine hydrochloride (LH) and magnetic iron oxide nanoparticles coated with a colorectal cancer (CRC) cell membrane (LH-Fe3O4@M) were prepared, for homologous targeting, magnetic resonance imaging (MRI), and chemotherapy. Results showed that the LH-Fe3O4@M and Fe3O4@M intensity at HT29 tumor was significantly higher than that Fe3O4@PEG, proving the superior selectivity of cancer cell membrane-camouflaged nanomedicine for homologous tumors and the MRI effect of darkening contrast enhancement were remarkable at HT29 tumor. The LH-Fe3O4@M exhibited excellent chemotherapy effect in CRC models as well as LH alone and achieved a high tumor ablation rate but no damage to normal tissues and cells. Therefore, our biomimetic system achieved a homologous targeting, bio-imaging, and efficient therapeutic effect of CRC.
引用
收藏
相关论文
共 418 条
  • [1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
  • [2] Ferlay J(2019)Global trends in colorectal cancer mortality: projections to the year 2035 Int J Cancer 144 2992-3000
  • [3] Soerjomataram I(2015)Colorectal cancer screening: a global overview of existing programmes Gut 64 1637-1649
  • [4] Siegel RL(2010)Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates Cancer 116 544-573
  • [5] Torre LA(2013)Extent and completeness of mesorectal excision evaluated by postoperative magnetic resonance imaging Br J Surg 100 1357-1367
  • [6] Jemal A(2014)Colorectal cancer statistics, 2014 CA Cancer J Clin 64 104-117
  • [7] Araghi M(2013)Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery Theranostics 3 986-1003
  • [8] Soerjomataram I(2022)Bionanoparticles in cancer imaging, diagnosis, and treatment VIEW 65 271-284
  • [9] Jenkins M(2022)Emerging biocompatible nanoplatforms for the potential application in diagnosis and therapy of deep tumors VIEW 10 1923-1947
  • [10] Brierley J(2000)Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 28 898-904